Srikar Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.42 Cr
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 51.15 Cr
- Satisfied Charges ₹ 46.91 Cr
- Revenue Growth 6.38%
- Profit Growth 18.85%
- Ebitda 28.87%
- Net Worth 27.76%
- Total Assets 23.03%
About Srikar Biotech
Srikar Biotech Private Limited (SBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 May 2008 and has a history of 16 years and nine months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.42 Cr.
The company currently has active open charges totaling ₹51.15 Cr. The company has closed loans amounting to ₹46.91 Cr, as per Ministry of Corporate Affairs (MCA) records.
Srinivasa Linga and Usha Papineni serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85100TG2008PTC059337
- Company No.
059337
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Srikar Biotech Private Limited offer?
Srikar Biotech Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Agro Chemicals, Medical Surgery & Treatment Centres, Medical Treatment Services, Insecticides and Pesticides, Termiticide, Fertilizers and Soil Additives, Fertilizer, Precious Stones and Gemstones, Garnet Stone.
Who are the key members and board of directors at Srikar Biotech?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Srinivasa Linga ![]() | Director | 26-May-2008 | Current |
Usha Papineni ![]() | Director | 26-May-2008 | Current |
Financial Performance of Srikar Biotech.
Srikar Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.38% increase. The company also saw a substantial improvement in profitability, with a 18.85% increase in profit. The company's net worth Soared by an impressive increase of 27.76%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Srikar Biotech?
In 2023, Srikar Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹51.15 Cr
₹46.91 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 31.71 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 15.15 Cr
- Others : 3.86 Cr
- Axis Bank Limited : 0.43 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
22 Sep 2023 | Hdfc Bank Limited | ₹1.39 M | Open |
26 May 2023 | Hdfc Bank Limited | ₹1.13 M | Open |
08 May 2023 | Hdfc Bank Limited | ₹1.01 M | Open |
02 May 2023 | Hdfc Bank Limited | ₹0.84 M | Open |
02 May 2023 | Hdfc Bank Limited | ₹1.14 M | Open |
How Many Employees Work at Srikar Biotech?
Srikar Biotech has a workforce of 61 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Srikar Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srikar Biotech's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.